Skip to main content
. 2015 Oct 6;5(10):e008350. doi: 10.1136/bmjopen-2015-008350

Figure 2.

Figure 2

Cumulative survival among 73 patients with lymphoma with left ventricular ejection fraction assessment before and after receiving anthracycline-based chemotherapy by the presence or absence of anthracycline-based chemotherapy-induced cardiomyopathy (CMP). Cumulative survival by presence or absence of CMP. The median years on study for survivors were 2.99 years.